On the public citation graph

Signatures for drug repositioning

0 signed · 15 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1126/scitranslmed.3001318openalex-snapshot
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
inferredcites →https://doi.org/10.1126/scitranslmed.3002648openalex-snapshot
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/0471250953.bi0808s45openalex-snapshot
Using VisANT to Analyze Networks
inferred← citeshttps://doi.org/10.1002/jcb.25799openalex-snapshot
An Integrative Drug Repurposing Pipeline: Switching Viral Drugs to Breast Cancer
inferred← citeshttps://doi.org/10.1016/j.bbrc.2026.153534openalex-snapshot
Evaluation of LG’s anticancer activity on human gastric cancer cell line HGC-27 via molecular docking and gene expression analysis
inferred← citeshttps://doi.org/10.1016/j.drudis.2012.07.014openalex-snapshot
Transcriptional data: a new gateway to drug repositioning?
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.114041openalex-snapshot
Repurposing mesalamine for acute kidney injury through supramolecular assembly
inferred← citeshttps://doi.org/10.1038/clpt.2012.83openalex-snapshot
The Role of Academic Institutions in the Development of Drugs for Rare and Neglected Diseases
inferred← citeshttps://doi.org/10.1093/nar/gkt401openalex-snapshot
VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies
inferred← citeshttps://doi.org/10.1096/fj.12-222992openalex-snapshot
Rifampin inhibits Toll‐like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain
inferred← citeshttps://doi.org/10.1101/560284openalex-snapshot
Identification of new inhibitors of the toxoplasma gondii by using in-silico drug repurposing
inferred← citeshttps://doi.org/10.1136/amiajnl-2014-002649openalex-snapshot
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-12-1243openalex-snapshot
A c-Myc Activation Sensor-Based High-Throughput Drug Screening Identifies an Antineoplastic Effect of Nitazoxanide
inferred← citeshttps://doi.org/10.1371/journal.pone.0177743openalex-snapshot
DrugSig: A resource for computational drug repositioning utilizing gene expression signatures
inferred← citeshttps://doi.org/10.4172/2167-1052.1000e117openalex-snapshot
Drug Repositioning: A Faster Path to Drug Discovery
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.